Drug Interactions between gadoxetate disodium and Mycobutin
This report displays the potential drug interactions for the following 2 drugs:
- gadoxetate disodium
- Mycobutin (rifabutin)
Interactions between your drugs
rifabutin gadoxetate
Applies to: Mycobutin (rifabutin) and gadoxetate disodium
MONITOR: Anionic drugs such as rifamycins may interfere with the hepatic contrast enhancement of gadoxetate by competing for biliary excretion. In animal studies, rifampin blocked the hepatic uptake and decreased the hepatic contrast effect of gadoxetate. The interaction has not been studied in human.
MANAGEMENT: Clinicians should be aware of possible interference with gadoxetate imaging in patients receiving rifamycin therapy.
References (1)
- (2008) "Product Information. Eovist (gadoxetate)." Bayer Pharmaceutical Inc
Drug and food interactions
No alcohol/food interactions were found. However, this does not necessarily mean no interactions exist. Always consult your healthcare provider.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.